United States · FDA National Drug Code directory
Tuxarin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71269-040_c64324ef-f77f-4467-844a-711a6b305582
- Product NDC
- 71269-040
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- codeine phosphate and chlorpheniramine maleate
- Labeler
- Mainpointe Pharmaceuticals
- Marketing category
- NDA
- Marketing start / end (source format)
- 20181015
- Source listing expiry
- 20261231
Source-listed ingredients
- CODEINE PHOSPHATE — 54.3 mg/1
- CHLORPHENIRAMINE MALEATE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71269-040-10) · 71269-040-10
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71269-040-30) · 71269-040-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →